Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Lilly to manufacture SangStat generic immunosuppressant

Nov. 15, 1996

ImmuLogic's Allervax products available for licensing

Nov. 8, 1996

FDA advisory committee deems ACEL-IMUNE safe and effective for use in infants

Nov. 8, 1996

ImClone licenses NIH patent for stem cell and gene therapy

Nov. 8, 1996

Bacterial meningitis virtually eliminated in U.S. following introduction of Hib vaccine

Nov. 8, 1996

Novel DNA vaccine induces immune response to HSV-2

Nov. 1, 1996

StressGen's core technology receives patent protection

Nov. 1, 1996

Three-dimensional structure of the T-cell receptor determined

Nov. 1, 1996

Takeda discloses vaccine candidates

Nov. 1, 1996

AM-94 available for licensing

Oct. 25, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 30, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026